Application 074827
- Type
- ANDA
- Sponsor
- ACP NIMBLE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | CAPTOPRIL; HYDROCHLOROTHIAZIDE | TABLET;ORAL | 25MG;15MG | No | No |
| 002 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | CAPTOPRIL; HYDROCHLOROTHIAZIDE | TABLET;ORAL | 25MG;25MG | No | No |
| 003 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | CAPTOPRIL; HYDROCHLOROTHIAZIDE | TABLET;ORAL | 50MG;25MG | No | No |
| 004 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | CAPTOPRIL; HYDROCHLOROTHIAZIDE | TABLET;ORAL | 50MG;15MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A074827-001 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | CAPTOPRIL; HYDROCHLOROTHIAZIDE | 25MG;15MG | TABLET / ORAL | 1997-12-29 | ||
| A074827-002 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | CAPTOPRIL; HYDROCHLOROTHIAZIDE | 25MG;25MG | TABLET / ORAL | 1997-12-29 | ||
| A074827-003 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | CAPTOPRIL; HYDROCHLOROTHIAZIDE | 50MG;25MG | TABLET / ORAL | 1997-12-29 | ||
| A074827-004 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | CAPTOPRIL; HYDROCHLOROTHIAZIDE | 50MG;15MG | TABLET / ORAL | 1997-12-29 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A074827-001 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | 25MG;15MG | TABLET / ORAL | 1997-12-29 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A074827-002 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | 25MG;25MG | TABLET / ORAL | 1997-12-29 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A074827-003 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | 50MG;25MG | TABLET / ORAL | 1997-12-29 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A074827-004 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | 50MG;15MG | TABLET / ORAL | 1997-12-29 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A074827-001 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | 25MG;15MG | TABLET / ORAL | 1997-12-29 | f41ea6bd6efb… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A074827-002 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | 25MG;25MG | TABLET / ORAL | 1997-12-29 | f41ea6bd6efb… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A074827-003 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | 50MG;25MG | TABLET / ORAL | 1997-12-29 | f41ea6bd6efb… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A074827-004 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | 50MG;15MG | TABLET / ORAL | 1997-12-29 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A074827-001 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | 25MG;15MG | TABLET / ORAL | 1997-12-29 | e64feba35796… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A074827-002 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | 25MG;25MG | TABLET / ORAL | 1997-12-29 | e64feba35796… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A074827-003 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | 50MG;25MG | TABLET / ORAL | 1997-12-29 | e64feba35796… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A074827-004 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | 50MG;15MG | TABLET / ORAL | 1997-12-29 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A074827-001 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | 25MG;15MG | TABLET / ORAL | 1997-12-29 | cb3db0bc1861… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A074827-002 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | 25MG;25MG | TABLET / ORAL | 1997-12-29 | cb3db0bc1861… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A074827-003 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | 50MG;25MG | TABLET / ORAL | 1997-12-29 | cb3db0bc1861… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A074827-004 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | 50MG;15MG | TABLET / ORAL | 1997-12-29 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A074827-001 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | 25MG;15MG | TABLET / ORAL | 1997-12-29 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A074827-002 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | 25MG;25MG | TABLET / ORAL | 1997-12-29 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A074827-003 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | 50MG;25MG | TABLET / ORAL | 1997-12-29 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A074827-004 | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | 50MG;15MG | TABLET / ORAL | 1997-12-29 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CAPTOPRIL AND HYDROCHLOROTHIAZIDE | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | Rising Pharma Holdings, Inc. | 0ea90fd4-0da6-4ad2-ab83-6cfbe0ae515e | 2023-02-21 | Boxed warning, Warnings, Adverse reactions | CAPTOPRIL AND HYDROCHLOROTHIAZIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.